Mechanistic Insight into Phenolic Compounds in Mitigating Diabetic Complications Induced by Advanced Glycation End Products
Current Issues in Molecular Biology · 14.10.2025 · 47 (10) · 841
DOI: 10.3390/cimb47100841 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 14.10.2025. Verfasst von Wajid Zaman und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Sciences, Yeungnam University, Gyeongsan 38541, Republic of Korea. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 230 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Diabetes mellitus is a chronic metabolic disorder that facilitates the formation of advanced glycation end products (AGEs), which contribute to oxidative stress, inflammation, and vascular damage, causing complications including nephropathy, neuropathy, and atherosclerosis. AGEs are primarily synthesized through the Maillard reaction, alongside various signaling pathways. Activation of the receptor for AGE (RAGE) triggers inflammatory signaling pathway cascades, exacerbating tissue damage. Phenolic compounds found in plant-based foods, such as quercetin and resveratrol, have shown promise in counteracting AGE-related complications through their antioxidant and anti-inflammatory effects that inhibit AGE formation, reduce oxidative stress, and modulate RAGE signaling, while also enhancing insulin sensitivity and improving glucose homeostasis. Indeed, quercetin can help prevent AGE accumulation and reduce diabetic nephropathy, while resveratrol activates the SIRT1 pathway, improving insulin sensitivity. This review examines the mechanisms through which phenolic compounds mitigate AGE-induced diabetic complications, using computational, in vitro, preclinical, and clinical evidence. This review also explores the synergistic effects of these compounds with conventional antidiabetic drugs, addresses bioavailability challenges, and suggests future research directions. Overall, this review offers a comprehensive understanding of the role of phenolic compounds in managing diabetes, underscoring their potential as complementary agents in diabetes therapy and developing more effective natural treatments.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Life Sciences, Yeungnam University, Gyeongsan 38541, Republic of Korea.
ORCID-Profile: Wajid Zaman, Adnan Amin
Zitieren
APA
Zaman, W., & Amin, A. (2025). Mechanistic Insight into Phenolic Compounds in Mitigating Diabetic Complications Induced by Advanced Glycation End Products. Current Issues in Molecular Biology, 47(10), 841. https://doi.org/10.3390/cimb47100841
Vancouver
Zaman W, Amin A. Mechanistic Insight into Phenolic Compounds in Mitigating Diabetic Complications Induced by Advanced Glycation End Products. Current Issues in Molecular Biology. 2025;47(10):841. doi:10.3390/cimb47100841
BibTeX
@article{Zaman2025,
author = {Zaman, Wajid and Amin, Adnan},
title = {Mechanistic Insight into Phenolic Compounds in Mitigating Diabetic Complications Induced by Advanced Glycation End Products},
journal = {Current Issues in Molecular Biology},
year = {2025},
volume = {47},
number = {10},
pages = {841},
doi = {10.3390/cimb47100841}
}
EUVIMED